Reata Pharmaceuticals, Inc.

DB:2R3 Stock Report

Market Cap: €6.2b

Reata Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

DB:2R3 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
14 Sep 23Sell€512,044Andrea Loewen-RodriguezIndividual3,175€161.27
05 Sep 23Sell€64,120Bhaskar AnandIndividual406€157.93
16 Aug 23Sell€186,465Dawn BirIndividual1,205€154.96
16 Aug 23Sell€424,480Colin MeyerIndividual2,740€154.99
16 Aug 23Sell€62,331Bhaskar AnandIndividual403€154.97
16 Aug 23Sell€186,623Michael WortleyIndividual1,205€154.96
16 Aug 23Sell€270,945Manmeet SoniIndividual1,755€154.38
14 Jun 23Sell€73,497Bhaskar AnandIndividual781€94.11
13 Jun 23Sell€5,540,043Manmeet SoniIndividual57,796€97.73
16 May 23Sell€101,119Dawn BirIndividual1,311€78.34
16 May 23Sell€48,994Samina KhanIndividual640€78.55
16 May 23Sell€100,899Michael WortleyIndividual1,311€78.08
16 May 23Sell€485,267Colin MeyerIndividual6,233€78.97
16 May 23Sell€85,362Bhaskar AnandIndividual1,086€79.16
16 May 23Sell€1,720,927Manmeet SoniIndividual22,132€78.85
16 May 23Sell€567,475Andrea Loewen-RodriguezIndividual7,166€79.42

Insider Trading Volume

Insider Buying: 2R3 insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of 2R3?
Owner TypeNumber of SharesOwnership Percentage
Private Companies60,1700.153%
Individual Insiders3,575,9579.11%
Hedge Funds4,554,86111.6%
Institutions31,075,62879.1%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 4.4%.


Top Shareholders

Top 25 shareholders own 78.48% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
12%
CPMG, Inc.
4,554,861€742.8m0%80.75%
7.41%
The Vanguard Group, Inc.
2,821,537€460.2m2.57%0.01%
6.72%
William Rose
2,559,011€417.3m-19.4%no data
6.66%
BlackRock, Inc.
2,538,770€414.0m14.9%0.01%
4.64%
Adage Capital Management, L.P.
1,766,070€288.0m276%0.67%
3.9%
Deutsche Asset & Wealth Management
1,486,467€242.4m-0.56%0.15%
3.86%
Wellington Management Group LLP
1,472,043€240.1m3.58%0.04%
3.85%
Dws Investment Gmbh
1,465,678€239.0m0%0.18%
3.76%
First Light Asset Management, LLC
1,432,208€233.6m-9.75%21.65%
3.75%
Tavistock Life Sciences
1,430,004€233.2m16.3%10.94%
2.76%
Janus Henderson Group plc
1,051,077€171.4m371%0.09%
1.87%
State Street Global Advisors, Inc.
713,150€116.3m12.7%0.01%
1.76%
Perceptive Advisors LLC
670,206€109.3m-69.1%3.81%
1.75%
Holocene Advisors, LP
667,950€108.9m119%0.53%
1.56%
Geode Capital Management, LLC
593,430€96.8m8.03%0.01%
1.5%
Emerald Advisers, LLC
572,483€93.4m0.5%2.66%
1.5%
Citadel Advisors LLC
571,529€93.2m1,670%0.13%
1.49%
Point72 Asset Management, L.P.
568,151€92.7m42.4%0.26%
1.46%
Millennium Management LLC
556,264€90.7m160%0.1%
1.31%
Radoff Family Foundation, Endowment Arm
500,000€81.5m0%95.11%
1.19%
Farallon Capital Management, L.L.C.
451,700€73.7m39%0.58%
1.07%
Fred Alger Management, LLC
407,170€66.4m133%0.37%
0.96%
Richard McGaughy
363,863€59.3m0.41%no data
0.9%
TimesSquare Capital Management, LLC
344,580€56.2m10,000%0.82%
0.89%
Blackstone Life Sciences
340,793€55.6m0%39.45%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.